Pneumonia as a cause of death in patients with lung cancer

Radiology and Oncology

Volumn 37, Issue 3, 2003, Pages

  Ziȩba, Marek ^a   Baranowska, Agnieszka ^a   Krawczyk, Michał ^a   Noweta, Krzysztof ^a   Grzelewska Rzymowska, Iwona ^a   Kwiatkowska, Sylwia ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Lung neoplasms; Pneumonia mortality

Indexed keywords

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; HOSPITALIZATION; HUMAN; IMMUNITY; INFECTION; LEUKOCYTE COUNT; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; RETROSPECTIVE STUDY; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY;

EID: 0142246315     PISSN: 13182099     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Jassem J, Papliński Z. Lung cancer. Warszawa: PZWL; 1994.
2. Remiszewski P. Supporting care in lung cancer. Nowa Klinika 1999; 6: 324-28.
3. Spiro SG. Lung cancer. Eur Respir Monogr 2001; 17: 22-48.
4. Brown BW, Brauner C, Minnotte MC. Noncancer deaths in white adult cancer patients. J Natl Cancer Inst 1993; 85: 979-87.
5. Zych J, Szymańska D, Drozd I, Słupek A, Rowińska-Zakrzewska E. Infections as a cause of death in patients with lung cancer. Pneumonol Pol 1984; 52: 11-7.
6. Remiszewski P, Słodkowska J, Wiatr E, Zych J, Załȩ ska J, Radzikowska E, et al. Infections as a main and additional cause of death in patients treated due to small cell lung cancer. Pneumonol Alergol Pol 1999; 67: 347-53.
7. Varthalitis I, Aoun M, Daneau D, Meunier F. Pneumocystis carinii Pneumonia in patients with cancer. Cancer 1993; 71: 481-5.
8. Mulder J. Haemophilus influenzae as an ubiquitous cause of common acute and chronic purulent bronchitis. Acta Med Scand 1938; 43: 94-8.
9. Lanyi M. Uber den begriff des bakteriellen bronchialinfektes. Dtsch Med Wschr 1968; 49: 2390-93.
10. Putinati S, Trevisani L, Gualandi M, Guerra G, Rossi MR, Sartori S, et al. Pulmonary infections in lung cancer patients at diagnosis. Lung Cancer 1994; 11: 243-9.
11. Nagata N, Nikaido Y, Kido M, Ishibashi T, Sueishi K. Terminal pulmonary infections in patients with lung cancer. Chest 1993; 103: 1739-42.
12. Maschmeyer G, Link H, Hiddemann W, Meyer P, Helmerking H, Eisenmann E, et al. Pulmonary Infiltrations in Febrile Patients with Neutropenia. Cancer 1994; 73: 2296-304.
13. Masur H, Shelhamer J, Parrillo JE. The management of pneumonias in immunocompromised patients. JAMA 1985; 235: 1769-73.
14. Tamm M, Traenkle P, Grilli B, Soler M, Bollinger CT, Dalquen P, et al. Pulmonary cytomegalovirus infection in immunocompromised patients. Chest 2001; 119: 838-43.
15. Remiszewski P, Słodkowska J, Wiatr E, Szczepek B, Radomski P, Rowińska-Zakrzewska E. Mycosis and pneumocystis carini pneumonia as a cause of death in patients treated due to small cell lung cancer. Pneumonol Alergol Pol 1998; 66 (Suppl 2): S173.
16. Kuan-Yu C, Shiann-Chin K, Po-Ren H, Kwen-Tay L, Pan-Chyr Y. Pulmonary fungal infection, emphasis on microbiological spectra, patient outcome and prognostic factors. Chest 2001; 120: 177-84.
17. Kanda Y, Yamamoto R, Chizuka A, Hamaki T, Suguro M, Arai Ch, et al. Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized controlled trials. Cancer 2000; 89: 1611-25.
18. Fossieck BE, Spagnolo SV. Pneumocystis carinii pneumonitis in patients with lung cancer. Chest 1980; 78: 721-2.
19. Talcott JA, Siegel RD, Finberg R, Goldmann L. Risk assessment in cancer patients with fever and neutropenia: A prospective, two-centre validation of a prediction rule. J Clin Oncol 1992; 10: 316-22.
20. Jarvis WR. Epidemiology of nosocomial fungal infections with emphasis of Candida species. Clin Infect Dis 1995; 20: 1526-30.
21. Rubenstein EB, Rolston K, Benjamin RS, Loewy J, Escalante C, Manzullo E, et al. Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer 1993; 71: 3640-6.
22. van Meerten E, Verweij J, Schellens JHM. Antineoplastic agents. Drug interaction of clinical significance. Drug Staf 1995; 12: 168-82.
23. Law A, Karp DD, Dipetrillo T, Daly BT. Emergence of increased cerebral metastasis after high dose preoperative radiotherapy with chemiotherapy in patients with locally advanced nonsmall cell lung carcinoma. Cancer 2001; 92: 160-4.
24. Remiszewski P, Stodkowska J, Szczepek B, Zwolska Z, Radomski P, Byszewska D, et al. Etiology of infection as a main and additional cause of death in patients treated due to small cell lung cancer. Pneumonol Alergol Pol 1999; 67: 354-61.
25. Earle CC, Stewart DJ, Cormier Y, Evans WK, Gertler SZ, Mihalcioiu C, et al. A phase I study of gemcitabine/cisplatin/etoposid in the treatment of small-cell lung cancer. Lung Cancer 1998; 22: 235-41.
26. Ali MA, Kraut MJ, Valdivieso M, Merskovic AM, Du W, Kalemkerian GP. Phase II study of hiperfractionated radiotherapy and concurrent weekly alternating chemiotherapy in limited-stage small cell lung cancer. Lung Cancer 1998; 22: 39-44.
27. Nowak D, Ziȩba M, Zawiasa D, RoNniecki J, Król M. Changes of serum concentration of lipid peroxidation products in patients with pneumonia. Monaldi Arch Chest Dis 1996; 51: 188-93.
28. Kwiatkowska S, Piasecka G, Ziȩba M, Piotrowski W, Nowak D. Increased serum concentration of conjugated dienes and malondialdehyde in patients with pulmonary tuberculosis. Respir Med 1999; 93: 272-6.
29. Kwiatkowska S, Kuźmińska B, Ziȩba M, Kroczyńska-Bednarek J, Kuna P. Enhanced concentration of cerculating ICAM-1 and TNF receptor I in patients with pulmonary tuberculosis. Current Pneumology 1999; 3: 225-30.